Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2013 Nov 29;28848:34428-42. doi: 10.1074/jbc.M113.512582.
Show Gene links
Show Anatomy links
Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
Grishin AA, Cuny H, Hung A, Clark RJ, Brust A, Akondi K, Alewood PF, Craik DJ, Adams DJ.
???displayArticle.abstract???
α-Conotoxin AuIB is a selective α3β4 nicotinic acetylcholine receptor (nAChR) subtype inhibitor. Its analgesic properties are believed to result from it activating GABAB receptors and subsequently inhibiting CaV2.2 voltage-gated calcium channels. The structural determinants that mediate diverging AuIB activity at these targets are unknown. We performed alanine scanning mutagenesis of AuIB and α3β4 nAChR, homology modeling, and molecular dynamics simulations to identify the structural determinants of the AuIB·α3β4 nAChR interaction. Two alanine-substituted AuIB analogues, [P6A]AuIB and [F9A]AuIB, did not inhibit the α3β4 nAChR. NMR and CD spectroscopy studies demonstrated that [F9A]AuIB retains its native globular structure, so its activity loss is probably due to loss of specific toxin-receptor residue pairwise contacts. Compared with AuIB, the concentration-response curve for inhibition of α3β4 by [F9A]AuIB shifted rightward more than 10-fold, and its subtype selectivity profile changed. Homology modeling and molecular dynamics simulations suggest that Phe-9 of AuIB interacts with a two-residue binding pocket on the β4 nAChR subunit. This hypothesis was confirmed by site-directed mutagenesis of the β4-Trp-59 and β4-Lys-61 residues of loop D, which form a putative binding pocket. AuIB analogues with Phe-9 substitutions corroborated the finding of a binding pocket on the β4 subunit and gave further insight into how AuIB Phe-9 interacts with the β4 subunit. In summary, we identified critical residues that mediate interactions between AuIB and its cognate nAChR subtype. These findings might help improve the design of analgesic conopeptides that selectively "avoid" nAChR receptors while targeting receptors involved with nociception.
Adams,
Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.
2013, Pubmed
Adams,
Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.
2013,
Pubmed Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed Armishaw,
Conotoxins as research tools and drug leads.
2005,
Pubmed Azam,
Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.
2005,
Pubmed
,
Xenbase Azam,
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.
2009,
Pubmed Billen,
Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein.
2012,
Pubmed
,
Xenbase Bjelkmar,
Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models.
2010,
Pubmed Brams,
Crystal structures of a cysteine-modified mutant in loop D of acetylcholine-binding protein.
2011,
Pubmed Callaghan,
Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation.
2008,
Pubmed
,
Xenbase Callaghan,
Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
2010,
Pubmed Celie,
Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.
2005,
Pubmed
,
Xenbase Clark,
Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design.
2006,
Pubmed Clark,
The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1.
2006,
Pubmed
,
Xenbase Cuny,
γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins.
2012,
Pubmed Dougherty,
The cation-π interaction.
2013,
Pubmed Dutertre,
Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase Dutton,
A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity.
2002,
Pubmed Franco,
RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
2012,
Pubmed
,
Xenbase Gallivan,
Cation-pi interactions in structural biology.
1999,
Pubmed Gay,
Structural determinates for apolipoprotein E-derived peptide interaction with the alpha7 nicotinic acetylcholine receptor.
2007,
Pubmed
,
Xenbase Gay,
Aromatic residues at position 55 of rat alpha7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization.
2008,
Pubmed
,
Xenbase Gehrmann,
Solution structure of alpha-conotoxin ImI by 1H nuclear magnetic resonance.
1999,
Pubmed Grishin,
Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase Grishin,
Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.
2010,
Pubmed
,
Xenbase Halai,
Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
2009,
Pubmed
,
Xenbase Han,
Conus venoms - a rich source of peptide-based therapeutics.
2008,
Pubmed Hansen,
Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
2007,
Pubmed Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed Harvey,
Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors.
1997,
Pubmed
,
Xenbase Harvey,
Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits.
1996,
Pubmed
,
Xenbase Hibbs,
Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
2009,
Pubmed Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed Hurst,
Nicotinic acetylcholine receptors: from basic science to therapeutics.
2013,
Pubmed Improgo,
The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.
2010,
Pubmed Innocent,
Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
2008,
Pubmed
,
Xenbase Inserra,
Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors.
2013,
Pubmed Janes,
alpha-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses.
2005,
Pubmed Kapono,
Conotoxin truncation as a post-translational modification to increase the pharmacological diversity within the milked venom of Conus magus.
2013,
Pubmed Kesters,
Structural basis of ligand recognition in 5-HT3 receptors.
2013,
Pubmed Klimis,
A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
2011,
Pubmed Lee,
Molecular docking study on the α3β2 neuronal nicotinic acetylcholine receptor complexed with α-conotoxin GIC.
2012,
Pubmed Lester,
Cys-loop receptors: new twists and turns.
2004,
Pubmed Lewis,
Therapeutic potential of venom peptides.
2003,
Pubmed Luo,
alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.
1998,
Pubmed
,
Xenbase Marx,
NMR of conotoxins: structural features and an analysis of chemical shifts of post-translationally modified amino acids.
2006,
Pubmed Millar,
Diversity of vertebrate nicotinic acetylcholine receptors.
2009,
Pubmed Morris,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
2009,
Pubmed Olivera,
Diversity of Conus neuropeptides.
1990,
Pubmed Parker,
Determinants of agonist binding affinity on neuronal nicotinic receptor beta subunits.
2001,
Pubmed
,
Xenbase Pereira,
Alpha-conotoxin-ImI: a competitive antagonist at alpha-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons.
1996,
Pubmed Puskar,
Two neuronal nicotinic acetylcholine receptors, alpha4beta4 and alpha7, show differential agonist binding modes.
2011,
Pubmed
,
Xenbase Quiram,
Pairwise interactions between neuronal alpha7 acetylcholine receptors and alpha-conotoxin ImI.
1999,
Pubmed Rogers,
NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors.
1999,
Pubmed Rucktooa,
Insight in nAChR subtype selectivity from AChBP crystal structures.
2009,
Pubmed Samanta,
Packing of aromatic rings against tryptophan residues in proteins.
1999,
Pubmed Sandall,
A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo.
2003,
Pubmed Satkunanathan,
Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones.
2005,
Pubmed Schnölzer,
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences.
1992,
Pubmed Seo,
The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase Shiembob,
Determinants of alpha-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit.
2006,
Pubmed Taly,
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
2009,
Pubmed Tapper,
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
2004,
Pubmed Terlau,
Conus venoms: a rich source of novel ion channel-targeted peptides.
2004,
Pubmed Ulens,
Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
2006,
Pubmed Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed Van Der Spoel,
GROMACS: fast, flexible, and free.
2005,
Pubmed van Lierop,
Dicarba α-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors.
2013,
Pubmed
,
Xenbase Williams,
Differential regulation of receptor activation and agonist selectivity by highly conserved tryptophans in the nicotinic acetylcholine receptor binding site.
2009,
Pubmed
,
Xenbase Wishart,
1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects.
1995,
Pubmed Wu,
beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells.
2004,
Pubmed Xie,
Contributions of Torpedo nicotinic acetylcholine receptor gamma Trp-55 and delta Trp-57 to agonist and competitive antagonist function.
2001,
Pubmed
,
Xenbase Xiu,
Nicotine binding to brain receptors requires a strong cation-pi interaction.
2009,
Pubmed
,
Xenbase Young,
Species selectivity of a nicotinic acetylcholine receptor agonist is conferred by two adjacent extracellular beta4 amino acids that are implicated in the coupling of binding to channel gating.
2007,
Pubmed Yu,
Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
2013,
Pubmed Yu,
Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.
2011,
Pubmed
